"The Wits University Donald Gordon Medical Centre (WDGMC) is the first private academic hospital in South Africa. It was established when the University of the Witwatersrand bought the Kenridge Hospital in Parktown with a founding donation from the Donald Gordon Trust. In 2005 Mediclinic Southern Africa became a partner with Wits University and was also awarded the management contract. The hospital was established to create a facility in the private sector for training of sub-specialists. This training programme is part of and complementary to the existing training programmes at The Charlotte Maxeke Johannesburg Academic Hospital, Chris Hani Baragwanath and Helen Joseph hospitals."

During the past decade, Wits Donald Gordon Clinical Trial Centre; Medical Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology" are "Breast Cancer" (3 trials), "Neoplasms" (2 trials), "Anemia" (1 trials), "Breast Neoplasms" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "5-Fluorouracil" (2 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials) and "Epirubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wits Donald Gordon Clinical Trial Centre; Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wits Donald Gordon Clinical Trial Centre; Medical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wits Donald Gordon Clinical Trial Centre; Medical Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".